Patent · US Active

Systems and methods using biomarker panel data

US10502747B2 · kind B2 · utility

0Cited by
7References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 31, 2013
Grant dateDec 10, 2019
Priority date
Expiry dateNov 27, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Embodiments of the disclosure are related to systems and methods for utilizing biomarker panel data with respect to medical devices and methods, amongst other things. In an embodiment, the disclosure can include a method of predicting the likelihood of response to CRT therapy. The method can include quantifying levels of one or more biomarkers in a biological sample of a patient, analyzing the quantified levels to determine response to CRT therapy, wherein a panel of biomarkers includes at least two selected from the group consisting of CRP, SGP-130, sIL-2R, sTNFR-II, IFNg, BNP, sST2, MMP-2, MMP-9, TIMP-1, TIMP-2, TIMP-4. Other embodiments are also included herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.